Atb Cap Markets upgraded shares of STERIS’ (TSE:STE – Free Report) to a strong-buy rating in a research note released on Sunday,Zacks.com reports.
STERIS’ Price Performance
STERIS’ Company Profile
STERIS’s MISSION IS TO HELP OUR CUSTOMERS CREATE A HEALTHIER AND SAFER WORLD by providing innovative healthcare and life science product and service solutions around the globe by providing innovative healthcare and life science product and service solutions around the globe.
Featured Articles
- Five stocks we like better than STERIS’
- Best of the list of Dividend Aristocrats: Build wealth with the aristocrat index
- 5 Reasons DraftKings Stock Looks Promising in the New Year
- Do ETFs Pay Dividends? What You Need to Know
- Cybersecurity Stocks: 1 Immediate Buy and 1 Dip Opportunity
- What is a SEC Filing?
- The Next 2 AI Winners Have Triple-Digit Upside Potential
Receive News & Ratings for STERIS’ Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for STERIS’ and related companies with MarketBeat.com's FREE daily email newsletter.
